Blood centres that fail quality checks may face testing curbs
The government may make participation of roughly 5,000 registered blood centres in India in external quality checks legally binding under the Drugs Rules, 1945.
The proposals submitted to India's top drug-regulatory advisory body suggest that blood centres in India which fail mandatory quality audits may soon face restrictions on conducting routine testing. The centres would be required to identify the cause of the failure and rectify the issue before resuming testing activities. Priyanka Sharma, a journalist with Mint, reports on the Union Ministry of Health and the pharmaceutical industry, explaining government policies and their impact on healthcare and the medicine market in India.
With a background in journalism and public health, Sharma has worked at India Today, The Pioneer, ANI and as a lead consultant for the National Health Authority.
Written by urgent.news from Live Mint's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.